NCT06200246

Brief Summary

The goal of this pilot study is to investigate energy transfer fram the ventricle to the arteries in patients with heart failure, primary by investigating the total power.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 28, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 10, 2024

Completed
Last Updated

January 10, 2024

Status Verified

December 1, 2023

Enrollment Period

9 months

First QC Date

December 28, 2023

Last Update Submit

December 28, 2023

Conditions

Heart Failure, Left-sided

Outcome Measures

Primary Outcomes (1)

  • Cardio vascular energy transfer in heart failure patients.

    We are investigating cardio vascular energy transfer in heart failure patients by calculating total power.

    During first 1-3 days after admission to hospital because of decompensated heart failure.

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population comprises individuals experiencing decompensated heart failure within the first three days of hospital admission. It includes both newly diagnosed cases and individuals with a pre-existing heart failure diagnosis. The population is diverse, both regarding gender and etiology.

You may qualify if:

  • Acute left ventricular failure due to:
  • Myocardial ischemia
  • Cardiomyopathy
  • Myocarditis Sinus rhythm Age \>18 years

You may not qualify if:

  • Cardiogenic shock Mechanical circulatory support Respiratory treatment Inotropic infusions Tachyarrhythmias Lack of capacity to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Olav hospital

Trondheim, Norway

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2023

First Posted

January 10, 2024

Study Start

October 1, 2022

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

January 10, 2024

Record last verified: 2023-12

Locations

NO(1)